Clinical Trial

Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block

Study acronym: ANPvsGPF block
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this pilot randomized controlled trial is to compare pain relief efficacy while using nasal packing versus greater palatine foramen block (GPFB) in the management of acute episodes of epistaxis. The main questions it aims to answer are: Does GPFB have less potential to inflict pain when dealing with hemostasis with epistaxis, utilizing a pre-validated 10-point visual analog scale (VAS)? Was hemostasis management more effective in either technique? Researchers will compare anterior nasal packing to greater palatine foramen block using 2% xylocaine with adrenaline. Patients will receive any of the hemostatic interventions at the time of the acute epistaxis episode. The questionnaire will be administered 24 hours post-intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-12.
Trial Details
NCT Number NCT07421622
Lead Sponsor Sheikh Zayed Federal Postgraduate Medical Institute
Conditions Epistaxis Nosebleed, Greater Palatine Foramen
Enrollment 40 participants
Start Date 2026-03-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-02-24